uniQure NV (QURE)
24.51
-14.60
(-37.33%)
USD |
NASDAQ |
Sep 29, 16:00
25.00
+0.49
(+2.00%)
Pre-Market: 09:28
uniQure Total Liabilities (Quarterly) : 661.05M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 661.05M |
| March 31, 2026 | 629.36M |
| December 31, 2025 | 626.01M |
| September 30, 2025 | 659.64M |
| June 30, 2025 | 588.89M |
| March 31, 2025 | 571.72M |
| December 31, 2024 | 563.29M |
| September 30, 2024 | 589.98M |
| June 30, 2024 | 633.74M |
| March 31, 2024 | 623.30M |
| December 31, 2023 | 624.02M |
| September 30, 2023 | 602.77M |
| June 30, 2023 | 589.45M |
| March 31, 2023 | 218.23M |
| December 31, 2022 | 228.96M |
| September 30, 2022 | 217.06M |
| June 30, 2022 | 214.72M |
| March 31, 2022 | 211.15M |
| December 31, 2021 | 213.40M |
| September 30, 2021 | 183.87M |
| June 30, 2021 | 150.66M |
| March 31, 2021 | 135.16M |
| December 31, 2020 | 96.49M |
| September 30, 2020 | 122.61M |
| June 30, 2020 | 119.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 119.10M |
| December 31, 2019 | 125.57M |
| September 30, 2019 | 121.36M |
| June 30, 2019 | 121.02M |
| March 31, 2019 | 111.88M |
| December 31, 2018 | 94.30M |
| September 30, 2018 | 81.21M |
| June 30, 2018 | 90.12M |
| March 31, 2018 | 91.98M |
| December 31, 2017 | 120.28M |
| September 30, 2017 | 119.38M |
| June 30, 2017 | 130.68M |
| March 31, 2017 | 132.53M |
| December 31, 2016 | |
| September 30, 2016 | 133.01M |
| June 30, 2016 | 136.11M |
| March 31, 2016 | 138.59M |
| December 31, 2015 | 133.20M |
| September 30, 2015 | 138.63M |
| June 30, 2015 | 125.92M |
| March 31, 2015 | 60.53M |
| December 31, 2014 | 63.77M |
| September 30, 2014 | 63.32M |
| June 30, 2014 | 63.54M |
| March 31, 2014 | 53.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Kymera Therapeutics, Inc. | 136.19M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Twist Bioscience Corp. | 226.70M |
| GRAIL, Inc. | 301.03M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 985.10M |
| Shareholders Equity (Quarterly) | 324.05M |
| Debt to Equity Ratio | 1.704 |
| Current Ratio | 10.01 |
| Net Debt Paydown Yield | -0.25% |